Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mutant Protein Developed By Hebrew University Scientists

17.03.2005


A unique technique for neutralizing the action of the leptin protein in humans and animals – thereby providing a means for controlling and better understanding of leptin function, including its role in unwanted cell growth -- has been developed by researchers at the Hebrew University of Jerusalem.


Three-dimensional structure of leptin. The region identified in the picture by numbers as amino acids 39, 40, 41, 42 underwent mutation that converted the normal leptin into an “antagonistic” version.



Leptin was discovered ten years ago and has attracted attention first because of its involvement in control of appetite and later by its effect on growth, puberty, digestion and immunological processes. Leptin can also have negative consequences, such as, for example, enhancing the spread of tumorous growths.

In his laboratory at the Hebrew University’s Faculty of Agricultural Food and Environmental Quality Sciences in Rehovot, Arieh Gertler, the Karl Bach Professor of Agricultural Biochemistry, along with his students, has developed a technique for genetically engineering mutations of the leptin protein. Prof. Gertler has been assisted in this work by graduate students Dana Gonen-Berger and Leonora Niv-Spector.and research assistant Gili Benyehuda.


In experimental work carried out cooperatively with researchers at the Agronomic Research Institute of France and the University of Paris VI, the scientists have developed a model showing which amino acids in leptin are responsible for activating leptin receptors in living cells. By replacing these amino acids with others, they were able to create a leptin variant that could bind with cell receptors, but would be unable to activate them, thereby providing a unique, novel research tool. In this way, the mutated leptin, with the substituted amino acids, acts as an “antagonist,” competing with the normal leptin for the “attention” of the cell receptors to which both leptins are attracted. The result is a “standoff” situation in which the normal leptin is neutralized.

Since leptin is involved in several cell functions, the development of this mutated “antagonistic leptin” could have significant consequences not only for better understanding of leptin action in animals but also on halting undesirable leptin effects in humans, such as undesired cell proliferation in cancer, or in controlling other pathological phenomena in which leptin is a factor.

Thus far, the researchers have succeeded in creating antagonists of human, sheep, rat and mouse leptins.

A company, Protein Laboratories Rehovot (PLR), that was formed by Prof. Gertler and the Hebrew University’s Yissum Research Development Company 18 months ago, was given the license to produce and market the mutated leptin products. Further development is currently being pursued towards testing whether leptin antagonists are capable of anti-cancer activity. This work is being pursued in cooperation with Prof. Nira Ben-Jonathan of the University of Cincinnati in the U.S., with the assistance of Prof. Gertler’s graduate student, Gila Ben Avraham.

Prof. Gertler has presented his work at a symposium of the Israeli Endocrinology Society and most recently at an international biotechnological conference in Miami, Fla., sponsored by the scientific journal Nature.

Jerry Barach | alfa
Further information:
http://www.huji.ac.il

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>